Loss of hepatic NF-kappa B activity enhances chemical hepatocarcinogenesis through sustained c-Jun N-terminal kinase 1 activation - Wikidata - awgldk - TriplyDB

Loss of hepatic NF-kappa B activity enhances chemical hepatocarcinogenesis through sustained c-Jun N-terminal kinase 1 activation

Loss of hepatic NF-kappa B activity enhances chemical hepatocarcinogenesis through sustained c-Jun N-terminal kinase 1 activation

http://www.wikidata.org/entity/Q34770928

about

JNK1 activation predicts the prognostic outcome of the human hepatocellular carcinoma Sustained JNK1 activation is associated with altered histone H3 methylations in human liver cancer The IKK complex contributes to the induction of autophagy CD95 promotes tumour growth JNK Signaling: Regulation and Functions Based on Complex Protein-Protein Partnerships The NF-κB Pathway and Cancer Stem Cells Regulatory Roles of MAPK Phosphatases in Cancer Interactions between Myc and Mediators of Inflammation in Chronic Liver Diseases The Crosstalk between Hypoxia and Innate Immunity in the Development of Obesity-Related Nonalcoholic Fatty Liver Disease Targeting RTK Signaling Pathways in Cancer Emerging role of Toll-like receptor 4 in hepatocellular carcinoma Are hematopoietic stem cells involved in hepatocarcinogenesis?Smad3 phospho-isoform signaling in hepatitis C virus-related chronic liver diseases JNK signalling in cancer: in need of new, smarter therapeutic targets Role of innate immunity in the development of hepatocellular carcinoma The stress-regulated transcription factor CHOP promotes hepatic inflammatory gene expression, fibrosis, and oncogenesis Divergent effects of PERK and IRE1 signaling on cell viability HCV Tumor Promoting Effect Is Dependent on Host Genetic Background Structural and functional analysis of the natural JNK1 inhibitor quercetagetin Activation of JNK and high expression level of CD133 predict a poor response to sorafenib in hepatocellular carcinoma Molecular mechanisms of liver injury and hepatocarcinogenesis: focusing on the role of stress-activated MAPK NF-κB, JNK, and TLR Signaling Pathways in Hepatocarcinogenesis Inflammation- and stress-related signaling pathways in hepatocarcinogenesis The NIEHS Superfund Research Program: 25 Years of Translational Research for Public Health A liver full of JNK: signaling in regulation of cell function and disease pathogenesis, and clinical approaches The potential interplay of adipokines with toll-like receptors in the development of hepatocellular carcinoma JNK-induced apoptosis, compensatory growth, and cancer stem cells TAK1 binding protein 2 is essential for liver protection from stressors Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression Loss of SPARC in bladder cancer enhances carcinogenesis and progression.The c-jun kinase/stress-activated pathway: regulation, function and role in human disease.Disruption of TAK1 in hepatocytes causes hepatic injury, inflammation, fibrosis, and carcinogenesis.Co-inhibition of NF-κB and JNK is synergistic in TNF-expressing human AML.Hepatocyte IKKbeta/NF-kappaB inhibits tumor promotion and progression by preventing oxidative stress-driven STAT3 activation Application of magnetic resonance imaging in transgenic and chemical mouse models of hepatocellular carcinoma.Hypoxia-inducible factor 2alpha regulates macrophage function in mouse models of acute and tumor inflammation Hepatocyte death: a clear and present danger.Phase II trial of bortezomib plus doxorubicin in hepatocellular carcinoma (E6202): a trial of the Eastern Cooperative Oncology Group Activation of c-Jun N-terminal kinase (JNK) during mitosis in retinal progenitor cells.

P2860

Q23919676-93B99212-F859-4AB5-8667-96335F474BA5 Q24170091-A7ABE21F-69A5-4556-B967-A563766DCE23 Q24329117-9D3DBDC3-3A5B-47C1-B225-6EB05A25D4C2 Q24602589-12C75208-A9A5-46EC-A7A1-F8C2BB2A710F Q26741279-468B3B43-5183-4CDE-B537-9FD1417DE48A Q26750605-23F50203-1FF7-4E5D-96B0-FBC3913ECFD3 Q26751025-B8B8EEA0-7708-46E4-B72E-ACEBBC56AEE5 Q26778328-4E9D1781-05A9-4045-845C-B0FBFDD8AF3D Q26780509-1104A1DF-1B12-4BDC-AF03-EAD906C878DA Q26781278-F7BEB6BF-D402-43E7-AA16-D592D86C9845 Q26824613-9A4761FA-8DEB-4886-BAEA-082438470C60 Q26830307-A8CC2E2F-3999-4C8C-BD93-496B20D335BE Q26863522-B55C57AD-C40E-4B0A-A03F-7F581B22C7DC Q27023869-930099CD-BBA1-41A4-AA37-F0334E38A1C1 Q27024780-1B8A70CB-83A8-48B0-9694-98E4632EAD4A Q27319729-FC27A89C-A6C8-4CED-9309-4A341596B1FB Q27438124-5C8AB67F-C6F6-435B-948F-A06CFD069447 Q27488251-513CA335-A845-42CA-AD1B-089FB77C25FC Q27675046-24744001-FF65-4FE3-89C6-105AEC04CBA1 Q27851797-0F4111C4-C1ED-4783-A708-0938CD619434 Q28384866-15FF1657-73A9-4CBE-9296-EC2FE390272D Q28384956-4D1D2919-3F0A-4802-B573-20E60845563E Q28387669-EA8E3CDA-C8E3-4943-BC22-3066F6AF93BB Q28390083-740B7A86-20A5-4A97-9ED4-8E4795CF8F56 Q28392033-C36BA0E4-607E-4D9F-AC5A-3BFC2FB59B59 Q28392224-11ACAE3A-AF88-4F4E-A2BE-EB352BCC167C Q28395713-07661511-9CFF-4F34-A6E1-48D6855CE9B9 Q28539471-BF458B4B-8DD5-4B3F-8E94-E4B7206A69F2 Q29614596-4885BB32-6E43-4B78-A31E-884094CD967E Q29615766-7ACA23B4-C7DF-45F7-B5C3-20743BEFB517 Q30422650-3077A926-E43D-46E2-A3B5-5125E858AAE4 Q30500831-50F0D3E6-4398-45AA-BEBE-2C4B3DAD641E Q33640296-44E834B4-35CC-4DFD-8B7C-67B74732B679 Q33703030-041F5077-8996-40E8-ABBF-B09EBA5E9FFA Q33737707-DF640B5F-642A-47CC-9751-F36C9F883DEC Q33846407-EB11A3D0-4ADE-491F-839B-C78D0EC9C946 Q34028645-3C936F81-96A0-44FD-BE66-5B2ADCE298C3 Q34147508-9397CA4D-3122-4986-B91D-8E832DD6F035 Q34225158-7864A95A-1DF2-467A-9337-CAC661525BA7 Q34230126-3D4002A0-CB4D-43CC-8F87-DE10745BA060

P2860

Loss of hepatic NF-kappa B activity enhances chemical hepatocarcinogenesis through sustained c-Jun N-terminal kinase 1 activation

http://www.wikidata.org/entity/Q34770928

description

2006 nî lūn-bûn

@nan

2006 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Loss of hepatic NF-kappa B act ...... N-terminal kinase 1 activation

@ast

Loss of hepatic NF-kappa B act ...... N-terminal kinase 1 activation

@en

Loss of hepatic NF-kappa B act ...... N-terminal kinase 1 activation

@nl

type

label

Loss of hepatic NF-kappa B act ...... N-terminal kinase 1 activation

@ast

Loss of hepatic NF-kappa B act ...... N-terminal kinase 1 activation

@en

Loss of hepatic NF-kappa B act ...... N-terminal kinase 1 activation

@nl

prefLabel

Loss of hepatic NF-kappa B act ...... N-terminal kinase 1 activation

@ast

Loss of hepatic NF-kappa B act ...... N-terminal kinase 1 activation

@en

Loss of hepatic NF-kappa B act ...... N-terminal kinase 1 activation

@nl

P1433

Q34770928-025F39E5-289F-4349-98CD-C54DB66F05B6

P1476

Q34770928-58735CF7-EDC2-4174-B058-136C320071E1

P2093

Q34770928-9D239074-9052-4260-BEFC-A7DDC24CAA60

Q34770928-A9C55478-4B07-4BCB-A2AD-11365C451BB5

Q34770928-CE8E8A47-20AC-4BA1-A39A-BA558326D5D0

P2860

Q34770928-00CC2D04-487F-4A5F-9198-83E28A3FA121

Q34770928-015988F8-2131-4161-A658-55EE0159A9A7

Q34770928-0275DE82-5AE1-465A-98DC-8CF08C388378

Q34770928-04321859-D038-496C-A1AF-99F45A042297

Q34770928-0578E338-2818-41DD-AFB6-8DF9C89E62DE

Q34770928-1AD2BBA0-6B6A-4E84-B5BF-1CD7245DC55E

Q34770928-1BD28BF8-A291-4109-8679-D68451341EA0

Q34770928-1E8425A1-B925-432C-B8E4-B96896937B64

Q34770928-239ED531-A710-4BCD-8BE4-4F46BDC5DC9A

Q34770928-2782634B-14DB-4820-8893-D80D72A92C68

P304

Q34770928-5021BC8A-7F9A-4168-98F1-D70170168FAA

P31

Q34770928-35D9A96A-A40C-4FA6-B541-BD2665EF4E5F

P356

Q34770928-91CE4439-5887-4F7C-96EF-AB23830D6668

P407

Q34770928-B9F1C66D-F9D6-4006-9E26-135506DAFBF0

P433

Q34770928-E6FF0D54-6C95-4939-A705-10C7F4CF7924

P478

Q34770928-60138761-9218-44DE-A874-225BBA054347

P50

Q34770928-5EF10BE5-DF78-4A21-BED4-6302D2DACD04

P577

Q34770928-4781C204-4715-4BDC-A706-E82ED80396AB

P5875

Q34770928-281809BB-D3BE-4DC6-A7DC-6794EC0C5A61

P698

Q34770928-CADD3ABF-00CF-4F86-BBCD-A5DC41D8DCB2

P921

Q34770928-C374487F-746D-491D-B897-6F248F62D5BD

P932

Q34770928-441D4742-C1D8-43B2-B5EB-6CBF5BCF4BB3

P356

PNAS.0603499103

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Loss of hepatic NF-kappa B act ...... N-terminal kinase 1 activation

@en

P2093

Lufen Chang

http://www.w3.org/2001/XMLSchema#string

Shin Maeda

http://www.w3.org/2001/XMLSchema#string

Toshiharu Sakurai

http://www.w3.org/2001/XMLSchema#string

P2860

IL-1beta-mediated up-regulation of HIF-1alpha via an NFkappaB/COX-2 pathway identifies HIF-1 as a critical link between inflammation and oncogenesis

MAGE-A4 interacts with the liver oncoprotein gankyrin and suppresses its tumorigenic activity

p53- and drug-induced apoptotic responses mediated by BH3-only proteins puma and noxa

Liver tumor development. c-Jun antagonizes the proapoptotic activity of p53

Reactive oxygen species promote TNFalpha-induced death and sustained JNK activation by inhibiting MAP kinase phosphatases

Functional analysis of the human cyclin D2 and cyclin D3 promoters

N-nitrosodiethylamine mechanistic data and risk assessment: bioactivation, DNA-adduct formation, mutagenicity, and tumor initiation

The E3 ubiquitin ligase itch couples JNK activation to TNFalpha-induced cell death by inducing c-FLIP(L) turnover

IL-1 is required for tumor invasiveness and angiogenesis

Missing pieces in the NF-kappaB puzzle

P304

10544-10551

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.0603499103

http://www.w3.org/2001/XMLSchema#string

P407

P433

28

http://www.w3.org/2001/XMLSchema#string

P478

103

http://www.w3.org/2001/XMLSchema#string

P50

P577

2006-06-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6977986

http://www.w3.org/2001/XMLSchema#string

P698

16807293

http://www.w3.org/2001/XMLSchema#string

P921

P932

1502270

http://www.w3.org/2001/XMLSchema#string